JAKARTA. PT Merck Tbk (MERK), a pharmaceutical company under Merck Holding GmbH from Germany, booked net profit of IDR 47.2 billion in the first half (H1) of 2024.

This number dropped 48.4% year-on-year (yoy) from the same period last year, in which MERK scored net profit of IDR 91.4 billion.

According to the recently released financial report, MERK’s net profit decline resulted from its revenue, which only managed to reach IDR 471.2 billion in H1 2024. Its revenue shrank 5.4% yoy to IDR 471.2 billion.

On the other hand, MERK’s costs of sales in H1 2024 also increased 8.3% yoy to IDR 318.99 billion. In the same period last year, costs of sales only clocked up to IDR 294.5 billion.

MERK’s total assets in H1 2024 were recorded at IDR 969.4 billion, while its total equity was reported at IDR 699.7 billion. (KR/ZH)